Arcus Biosciences, Inc. vs UnitedHealth Group Incorporated — Stock Comparison

RCUS
Arcus Biosciences, Inc.
$25.68
▲ 0.71%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
UnitedHealth Group Incorporated
UNH6.3/10vs 5.7/10

Q·Score Breakdown

5.7
Neutral
Overall
6.3
Neutral
0.2
Quality
6.2
9.2
Health
5.3
7.7
Growth
5.1
5.7
Valuation
7.3
7.2
Sentiment
8.1
RCUS

Clean balance sheet with low leverage (0.3× debt-to-equity).

currently unprofitable (-143% margin).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

BUY
Target $34.00 (+32.4%)
10 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

RCUS
UNH
Trailing P/E
27.9×
-7.3×
Forward P/E
17.8×
-142.9%
Profit Margin
2.7%
-111.7%
Gross Margin
18.8%
-63.3%
ROE
12.2%
26.9%
Revenue Growth
2.0%
Earnings Growth
0.7%
0.86
Beta
0.41
Price / Book
$3.2B
Market Cap
$334.9B
$7 – $29
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →